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ABSTRACT
Background Cone-rod dystrophy is a retinal dystrophy
with early loss of cone photoreceptors and a parallel or
subsequent loss of rod photoreceptors. It may be
syndromic, but most forms are non-syndromic with
autosomal dominant, autosomal recessive or X-linked
recessive inheritance.
Methods and results We identiﬁed a small
consanguineous family with six patients with cone-rod
dystrophy from the Faroe Islands. Homozygosity mapping
revealed a single homozygous locus of 4.2 Mb on
chromosome 10q23.1eq23.2, encompassing 11 genes.
All patients were homozygous for a 1-bp duplication in
PCDH21, c.524dupA, which results in a frameshift and
a premature stop codon (p.Q175QfsX47).
Conclusion To our knowledge, this is the ﬁrst report of
mutations in PCDH21 as a cause of human disease.
PCDH21 is highly expressed in the retinal photoreceptor
cells. It encodes protocadherin 21, which belongs to the
cadherin superfamily of large cell surface proteins
characterised by a variable number of extracellular
cadherin domains. A PCDH21 knockout mouse model has
previously shown loss of photoreceptor cells and
abnormal cone and rod function, similar to the ﬁndings in
the patients.
Cone-rod dystrophy (CORD (MIM 120970)) is
a group of inherited disorders that belong to the
generalised retinal dystrophies. The prevalence of
CORD is 1/40 000. CORD is characterised by early
loss of cone receptors accompanied by loss of rod
receptors, in contrast to retinitis pigmentosa (RP),
where the loss of cone photoreceptors occurs
secondarily to rod degeneration. The loss of cone
photoreceptor cells leads to visual loss, visual ﬁeld
loss, abnormalities of colour vision and variable
degrees of photophobia and nystagmus. The loss of
rod function leads to night blindness. The onset is
usually in late childhood or early adulthood.
Fundus examination shows focal macular retinal
pigment epithelial (RPE) atrophy or a bull’s eye
maculopathy in the early stages, and in the later
stages peripheral RPE atrophy, retinal hyperpig-
mentation, arteriolar attenuation and optic disc
pallor occurs. Absent or severely impaired cone
function is found on electroretinography (ERG) and
psychophysical testing.
CORD may be syndromic, for example, in
Alstrom syndrome and spinocerebellar ataxia type
7,
1 2 but most patients have non-syndromic CORD.
Several genes have been identiﬁed in non-
syndromic CORD: CRX, GUCY2D, RIM1, RDS,
GUCA1A and AIPL1 in autosomal dominant
CORD, RPGR in X-linked recessive CORD,
and ABCA4, RPGRIP1, CNGA3 and ADAM9 in
autosomal recessive CORD.
34In addition, four loci
are known, where the disease-causing gene has not
been yet been identiﬁed.
We have identiﬁed a small consanguineous family
with CORD from the Faroe Islands, which is
a small archipelago in the North Atlantic Ocean
between Iceland and Norway. The present popu-
lation was founded around 825 AD by migration
from the Western part of Norway
8 and remained
small and isolated for a long time, with an esti-
mated size of 4000 in the fourteenth century and
9000 in the nineteenth century. During the last
150 years, the population has expanded to the
present size of around 50000.
9 No major bottle-
necks are thought to have occurred.
5 A founder
effect is responsible for a high incidence of some
disorders in the Faroe Islands, for example, cystic
ﬁbrosis
6 and mitochondrial encephalomyopathy
with elevated methylmalonic acid.
7
METHODS
Human participants
The consanguineous family consists of three men
and three women affected with CORD (ﬁgure 1A).
Genealogical studies revealed a common ancestor
six generations back, born in 1687, of the parents of
patients II:4, II:6 and II:10, and the mutation
carrier III:1. The Faroese population has been
studied extensively for hereditary ophthalmological
disorders, but to our knowledge, no other Faroese
persons have a diagnosis of CORD.
The study complied with the ethical guidelines
of the Declaration of Helsinki. It was approved by
the Faroese Ethical Committee and carried out in
collaboration with the governmental Genetics
Resource Centre of the Faroe Islands. The family
gave informed consent for the study.
The pedigree analysis provided strong evidence of
autosomal recessive mode of inheritance, and all
affected persons were assumed homozygous for
a mutant allele.
DNA and RNA extraction and cDNA synthesis
DNA was extracted from peripheral blood using
standard procedures. RNA was extracted from
cultured ﬁbroblasts with the RNAeasy Mini kit
(Qiagen, Inc., Valencia, California, USA) and
reverse transcribed to cDNAwith the SuperScript II
Reverse Transcriptase kit (Invitrogen, Carlsbad,
California, USA).
Microarray analysis
DNA from the six affected patients (II:4, II:6, II:10,
IV:1, IV:2 and IV:3) was used for a genome-wide
search for homozygosity with the Affymetrix
GeneChip 50K Xba array (Affymetrix Inc., Santa
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Original articleClara,California,USA).Inbrief,250 ngofDNAwasdigestedwith
therestrictionenzymeXbaI,mixedwithXbaadaptersandligated
with the T4 DNA ligase. The ligated DNAwas PCR-ampliﬁed in
four PCRs, pooled and puriﬁed. The puriﬁed PCR product was
fragmented with DNase I and end-labelled with biotin. The
samples were hybridised to an array for 18 h in a hybridisation
oven. The array was washed, stained and scanned with an Affy-
metrix GeneChip scanner 3000. Affymetrix software was used to
analyse the data, which were exported to an Excel ﬁle.
Linkage analysis
Multipoint parametric linkage analysis was performed with the
GeneHunter program on the EasyLINKAGE V.5.08 plus plat-
form.
10 An autosomal recessive mode of inheritance with
complete penetrance was assumed, and the disease allele
frequency was set at 0.001.
Mutation analysis
PCR was performed with the Promega kit and the following
conditions: 0.2 mM dNTPs, 13 buffer, 1.5 mM MgCl2, 0.5 mM
of each primer, 10 ng template and 1.5 U polymerase in a total
volume of 50 ml. The PCR program was 94 C for 2 min, 35 cycles
of denaturing at 948C for 30 s, annealing at 608C for 30 s and
extension at 728C for 30 s and a ﬁnal extension step of 728C for
7 min. Primer sequences are available on request.
Sequencing was performed with ABI Big Dye Terminator v.
1.1 Cycle Sequencing Kit (Applied Biosystems, Foster City,
California, USA). The sequencing reactions were vacuum-puri-
ﬁed with the Montage Seq96 Sequencing Reaction Cleanup Kit
(Millipore SA, SaintQuentin, France) and analysed on an ABI
3130xl Gene Analyzer (Applied Biosystems).
ThedatawereanalysedwithSequencingAnalysisSoftwareV.5.2
from Applied Biosystems, and mutation screening was performed
using Mutation Surveyor V.3.1 Software (SoftGenetics).
RESULTS
Clinical ﬁndings
The three oldest affected siblings (patients II:4, II:6 and II:10)
reported decreased vision from around age 17 years. In addition
to CORD, two of the patients (patients IV:1 and IV:3) had
oculocutaneous albinism, which caused nystagmus and reduced
visual acuity from early infancy. The genetic background for
their albinism is unknown, but no mutations were found by
sequencing TYR and OCA2. Patient IV:2 denied visual difﬁculty
in daylight when examined at the age of 15. He had, however,
always had difﬁculties with nighttime orientation. Patient II:10
complained of impaired vision at night and of delayed adapta-
tion to sudden changes in light intensity.
Visual acuity varied between 0.67 and 0.02 (table 1). In patient
II:4, large inter-ocular differences in visual acuity were observed
due to a large scar in the left macula, which was likely caused by
a foetal toxoplasmosis infection. The inter-ocular difference in
visual acuity in patient II:10 was explained by a left-sided squint
in childhood.
Retinal examination showed both central and peripheral
pigment abnormalities (ﬁgure 2). The foveal changes consisted
of irregular pigmentation and atrophy of the RPE with a hori-
zontal oval-shaped or ill-deﬁned “moth-eaten” appearance. In
patient IV:2, the foveal regions had an extensive sheen. In the
two patients with oculocutaneous albinism (patients IV:1 and
IV:3), the changes in the foveal regions were less obvious due to
the scarcity of pigment. The peripheral pigment disturbances
included diffuse RPE atrophy and black hyperpigmentations of
polymorphic shape, some of which were ﬁliform and sheeted the
vessels. The amount of pigmentation varied considerably among
patients of the same age but showed some correlation to the
extent of visual ﬁeld constriction. In the oldest patients, the
optic discs looked moderately atrophic, and the retinal vessels
were universally constricted.
Figure 1 Pedigree of the family with
CORD, linkage analysis, genes in the
candidate region and mutation analysis
of PCDH21. (A) Pedigree of the
consanguineous family with a PCDH21
mutation. Filled symbols are
homozygous affected individuals, half-
ﬁlled symbols are heterozygous
carriers. (B) Results of the parametric
multipoint linkage analysis using
Genehunter software, which shows
a single signiﬁcant peak on
chromosome 10, with a LOD score of
3.1. (C) The 11 genes in the candidate
region on chromosome 10q23.1e23.2.
(D) Mutation analysis of PCDH21
shows the homozygous c.524dupA
mutation (left), a heterozygous carrier
(middle) and the wild-type (right). (E)
Analysis of cDNA from ﬁbroblasts from
a homozygous patient shows that the
mutation results in a frameshift (top).
Wild-type is shown for comparison
(bottom).
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Original articleVisual ﬁeld measurements with a large object showed
considerable variation; patient II:4 had only narrow peripheral
remnants left in the lower visual ﬁelds and a paracentral
preserved island of 108, whereas patients II:6 and II:10 had
normal or slightly constricted outer ﬁeld limits. In patient II:6,
a central scotoma measuring 58 was found. The smallest test
objects revealed concentric constriction in patients IV:1 and IV:2.
Colour vision was severely impaired in the two patients tested
(patients II:6 and II:10 at ages 36 and 38 years, respectively).
Dark adaptation was tested in two patients (patients II:10 and
IV:2 at ages 38 and 15 years, respectively). It showed a mono-
phasic and protracted course, with only a slight elevation of the
ﬁnal threshold of 0.5e1 log unit in patient II:10 (ﬁgure 3).
The ERG of patient II:10 showed severely reduced amplitudes
and prolonged photopic implicit times (table 1). Patient IV:1 had
normal amplitudes at the age of 2 years but prolonged cone
implicit times. Eight years later, the ERG showed absent
response to low-intensity stimuli and a 50% reduction in the
response to high-intensity ﬂash. In patient IV:2, the ERG
response was absent at age 17 years.
Patients II:6 and II:10 reported normal smell sense.
Mapping of a gene for CORD to chromosome 10
A frequent cause of CORD is mutations in ABCA4, and we,
therefore, analysed the SNP data for linkage to ABCA4.
Assuming autosomal recessive inheritance and a homozygous or
compound heterozygous mutation, we did not ﬁnd evidence of
linkage to ABCA4 (see online supplementary table 1).
Genome-wide analysis of SNP data for homozygosity revealed
a single homozygous region on chromosome 10q23.1eq23.2
(see online supplementary table 2); a signiﬁcant LOD score of
3.1 was found by multipoint linkage analysis (ﬁgure 1B). The
Table 1 Clinical and electrophysiological characteristics of patients with CORD caused by PCDH21 mutations
Patient
Age at
examination
(years) Sex
Visual
acuity
(right/left) Refraction (right/left)
ERG (right eye)
cone response*
(amplitude (mV)/implicit
time (ms))
ERG (right eye) rod
response* b-wave
(amplitude (mV)/
implicit time (ms))
ERG (right eye) cone-rod
response* aeb-wave
(amplitude (mV)/implicit
time (ms))
II:4 29 M 0.67/0.02 3.00/3.00 No response No response No response
II:6 36 F 0.10/0.10 2.251.503258/2.50e1.00308 10/42 132/80 140/62
II:10 37 M 0.60/0.10 0.00/0.00 16/40 No response 89/59
IV:1 2 F 0.08/0.08 5.503.00358/4.502.5031708 44/39 206/112 280/66
IV:2 17 M 0.16/0.67 0.00/0.00 No response No response No response
IV:3 1/2 F 0.20/0.20 4.501.50308/4.501.50308 55/32 No response 165/56
*ERG normal values. Cone scotopic ﬂicker response: amplitude median 94 mV, range 53e145 mV( 5 e95%), implicit time median 29.0 ms, range 27.0e34.0 ms (5e95%). Rod low-intensity
ﬂash response: b-wave amplitude median 210 mV, range 124e302 mV( 5 e95%), implicit time median 103.0 ms, range 81.0e123.0 ms (5e95%). Cone-rod high-intensity ﬂash response: aeb-
wave amplitude median 427 mV, range 285e674 mV( 5 e95%), implicit time median 48.0 ms, range 41.0e55.0 ms (5e95%).
Figure 2 Fundus pictures of the right eye. (A) Diffuse atrophy of the retinal pigment epithelium (RPE) and extensive sheen in the macular region
(patient II:4). (B) Numerous, polymorphic, intraretinal hyperpigmentations in the upper temporal midperiphery (patient II:4). (C) Irregular foveal
degeneration and normal arteriolar caliber (patient II:6). (D) Irregular RPE atrophy in the macular region, attenuated arterioles and paleness of the optic
nerve head (patient II:10). (E) Albinotic fundus masking the macular changes (patient IV:1). (F) Foveal atrophy and attenuated arterioles (patient IV:2).
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Original articlelinkage interval had a size of 4.2 Mb and was ﬂanked by the
heterozygous markers rs6584455 and rs868042 (ﬁgure 1C).
The region encompasses 11 genes, of which three were
candidate genes: RGR, which had previously been shown to
cause autosomal recessive retinitis pigmentosa in humans,
LRIT1, which is highly expressed in retina, and PCDH21, where
a knockout mouse model had shown loss of cone and rod
photoreceptor cells.
11e13
Screening of candidate genes
No mutations were found in RGR or LRIT1. Sequencing of
PCDH21 revealed a 1 bp insertion, c.524dupA (ﬁgure 1D). The
six patients were homozygous for the mutation, and 12 family
members were heterozygous carriers (ﬁgure 1A). Individuals II:1
and II:3 did not carry the mutation; no DNA was available from
the remaining family members.
The 1 bp duplication is expected to cause a frameshift
resulting in a premature stop codon (p.Q175QfsX47), which
was conﬁrmed by analysis of cDNA from ﬁbroblasts (ﬁgure 1E).
Screening of 159 anonymous Faroese controls for the muta-
tion revealed three heterozygous carriers, corresponding to
a carrier frequency of 1.9%. None of the controls were homo-
zygous for the mutation.
DISCUSSION
To our knowledge, this is the ﬁrst report of mutations in
PCDH21 as a cause of human disease. In a previous study, two
heterozygous missense mutations were found in three patients
with autosomal recessive RP, but a second mutation was not
found; hence, the pathogenicity of the mutations is unclear.
14
The PCDH21 mutation was identiﬁed in a small consan-
guineous family from the Faroe Islands, and a carrier frequency
of 1:53 (1.9%) was found. A high carrier frequency is found in
other disorders in the Faroe Islands that are caused by founder
mutations, for example cystic ﬁbrosis (1:24) and mitochondrial
encephalomyopathy with elevated methylmalonic acid (1:33).
8 9
PCDH21 was identiﬁed by Rattner et al by subtractive
hybridisation and high-throughput screening in a search for
genes speciﬁcally expressed in the retina.
13 At the same time,
Nakajima et al identiﬁed PCDH21 in a search for genes that
encode proteins with cadherin domains.
15 PCDH21 is conserved
among different vertebrate species but has not been found in
invertebrates. It is a member of the protocadherin family, the
largest subgroup within the cadherin superfamily of large cell
surface proteins characterised by a variable number of extracel-
lular cadherin domains.
16 The cadherins are involved in calcium-
dependent cellecell adhesion and are important in nervous
system function.
Cadherin/protocadherin genes have previously been shown to
be involved in disorders of the retina: mutations in the proto-
cadherin gene PCDH15 are responsible for Usher syndrome type
1F, and mutations in the cadherin genes CDH23 and CDH3 were
shown to cause Usher syndrome type 1D and hypotrichosis
with juvenile macular dystrophy, respectively.
17e19
PCDH21 has six predicted cadherin repeats and an intracel-
lular domain, which is not homologous to that of other
cadherins. PCDH21 is highly expressed the retina, more speciﬁ-
cally in the junction between the inner and outer segments (OS)
of rod and cone photoreceptors; the expression is also high in
olfactory bulbs, with a lower expression in the septum and
olfactory cortex.
13 15 PCDH21 expression is very low or absent in
heart, kidney, liver, lung, spleen, testis and skeletal muscle. The
photoreceptor OS is a derivative of a non-motile cilium that
contains phototransduction proteins organised in a stack of over
1000 discs. The discs are continuously renewed from the base,
and the older discs are shedded from the tip. The proteins are
synthesised in the inner segment and transported to the OS via
the connecting cilium.
PCDH21 undergoes a speciﬁc proteolytic cleavage, which
releases ectodomain as a soluble fragment. In rds knockout mice,
where the OS assembly is disturbed, the proteolytic cleavage is
inhibited and full-length PCDH21 accumulates.
20
Mutations in PROM1 have been identiﬁed in patients with
autosomal recessive RP, and PCDH21 protein has been shown to
interact with PROM1 by co-immunoprecipitation studies.
21
PROM1 is a transmembrane protein associated with plasma
membrane protrusions, and it co-localises with PCDH21 to the
base of the photoreceptor OS. In transgenic mice expressing
human PROM1 with a heterozygous missense mutation,
PROM1 and PCDH21 protein was found throughout the
photoreceptor layers instead of the normal localisation at the
base of the photoreceptor OS. In Pcdh21
/ mice, PROM1 mis-
localised throughout the OS. These ﬁndings suggest that the
interaction between PCDH21 and PROM1 is necessary for both
proteins to function normally.
Taken together, these ﬁndings suggest that PCDH21 is
involved in OS structure and/or assembly but not in photo-
transduction in rods and cones. This hypothesis is supported by
the localisation of PCDH21 to the base of the OS at the earliest
stages of differentiation of rods, before other OS proteins, for
example, rhodopsin, RP1 and ROM1, are found.
20
A PCDH21 knockout mouse model showed normal viability
and fertility without anatomical or behavioural abnormalities.
13
At age 1 month, the retinas appeared normal, but this was
followed by a progressive loss of photoreceptors, and a 50%
reduction in the number of photoreceptor cells was observed by
age 6 months, which likely is the result of apoptosis. Analysis of
photoreceptor electrical signalling showed 2- to 3-fold dimin-
ished saturating a-wave amplitude, which reﬂects rod photore-
ceptor function, in Pcdh21
/ mice compared to Pcdh21
+/+ and
Pcdh21
+/ mice. The saturating amplitude of the cone-driven
b-wave response was diminished about twofold in Pcdh21
/
mice. Electron microscopy showed that in Pcdh21
/ mice, the
OS were shorter with swirls of membranes with imperfectly
stacked discs. The inner segments and RPE appeared unaffected.
The knockout mouse thus had abnormal cone and rod function,
Figure 3 Dark adaptation in patients with CORD due to PCDH21
mutations. The dark adaptation curves in patients II:10 and IV:2 show
a protracted initial phase and an absent mesopic break, resulting in
a monophasic, straightened course compared to the normal diphasic
course.
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expected from the degree of disorganisation of the OS. The ERG
ﬁndings and the loss of photoreceptor cells in patients with
PCDH21 mutations were similar to those found in the knockout
mouse model. Despite the high PCDH21 expression in olfactory
bulbs, the patients showed no signs of decreased olfactory function.
The frameshift mutation found in PCHD21, one of three
sequenced genes of 11 candidate genes in the linkage interval, the
segregation of the mutation with the disease in the family, the
high and almost exclusive expression of the gene in the retina and
the similarity of the phenotype of the patients with that of
a knockout mouse heavily imply that autosomal recessive cone-
rod dystrophy in this family is caused by PCDH21 mutations.
Since several of the previously reported genes involved in CORD
have been shown to be involved in, for example, Stargardt
disease, Leber congenital amaurosis and RP, PCDH21 should be
considered a candidate gene for other retinal dystrophies.
Note Around the time of the acceptance of this paper,
PCDH21 mutations were reported in two families with retinal
dystrophy in Henderson RH, Li Z, Abd El Aziz MM, Mackay
DS, Eljinini MA, Zeidan M, Moore AT, Bhattacharya SS, Webster
AR. Biallelic mutation of protocadherin-21 (PCDH21) causes
retinal degeneration in humans. Mol Vis 2010;16:46e52.
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